Monocyclic L-nucleosides, analogs and uses thereof
First Claim
Patent Images
1. A compound having a structure according to Formula I, in which the sugar is in an L conformation:
3 Assignments
0 Petitions
Accused Products
Abstract
Novel monocyclic L-Nucleoside compounds have the general formula
Embodiments of these compounds are contemplated to be useful in treating a wide variety of diseases including infections, infestations, neoplasms, and autoimmune diseases. Viewed in terms of mechanism, embodiments of the novel compounds show immunomodulatory activity, and are expected to be useful in modulating the cytokine pattern, including modulation of Th1 and Th2 response.
3 Citations
4 Claims
- 1. A compound having a structure according to Formula I, in which the sugar is in an L conformation:
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeRibapharm Inc. (Bausch Health Cos., Inc.)
-
Original AssigneeRibapharm Inc. (Bausch Health Cos., Inc.)
-
InventorsAverett, Devron, Ramasamy, Kanda, Tam, Robert
-
Granted Patent
-
Time in Patent OfficeDays
-
Field of Search
-
US Class Current536/28.1
-
CPC Class CodesA61P 31/00 Antiinfectives, i.e. antibi...A61P 33/00 Antiparasitic agentsA61P 35/00 Antineoplastic agentsA61P 37/02 ImmunomodulatorsA61P 37/06 Immunosuppressants, e.g. dr...C07H 19/04 Heterocyclic radicals conta...
